The targeted integration of large DNA payloads into primary human T cells can be efficiently achieved non-virally by leveraging Cas9-based editing and the DNA-repair pathway homology-mediated end joining.
- Beau R. Webber
- Matthew J. Johnson
- Branden S. Moriarity